Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Harm Reduction Clinical Trial

Official title: Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Status Recruiting

Clinical Trial Summary

The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select courts in rural and urban communities in Ohio.

Clinical Trial Description

Purpose: Opioid-related fatalities are a leading cause of death in Ohio and nationally, with an increasing number of overdoses attributable to fentanyl. Rapid fentanyl test strips (FTS) test for the presence of some types of fentanyl in urine samples and are increasingly being used to check illicit drugs for fentanyl before they are used. FTS use is a promising harm reduction strategy and research shows when people who use drugs (PWUD) receive a positive result, they are more likely to perform overdose risk reduction behaviors. However, access to FTS is limited, and there are barriers to the adoption of this intervention in some communities. This study will investigate FTS distribution and education as a harm reduction strategy to prevent overdoses among PWUD. Study findings will contribute valuable information about the feasibility and acceptability of integrating FTS drug checking into court sites in rural and urban communities in Ohio and help study personnel achieve the long-term goal of reducing overdose deaths.

Study Design: Court sites that volunteer to participate in the study will be randomly assigned to either the intervention or non-intervention arm of the study.

Clients in the intervention arm of the study will receive:

• One-on-one education on the purpose, benefits, and limitations of FTS testing

• A brief 20-minute fentanyl test strip educational intervention, including a 2-3-minute video and hands-on demonstrations on how to use FTS

• A supply of FTS upon enrollment and throughout the 2-year follow up period

• Opioid overdose education and a naloxone kit upon enrollment and re-supply of naloxone as needed throughout the 2-year follow up period

Clients in the non-intervention arm of the study will receive:

• Opioid overdose education and a naloxone kit upon enrollment and re-supply of naloxone as needed throughout the 2-year follow up period

• FTS education and a supply of FTS will be offered to participants in the non-intervention arm in the last year of the study

Consent: Written documentation of informed consent will be obtained from all participants.

Recruitment and Retention: Having a close partnership with the Supreme Court of Ohio will help study staff recruit and retain study participants. In addition to key informant interviews in year one and questionnaires in year three, the research team will survey court managers quarterly to collect data on the court's satisfaction with the program and identify any areas of concern. The investigators will also maintain regular communication with court personnel when the study staff are onsite.

The research team will handle all enrollment of study clients, delivery of the FTS intervention, and follow up with study participants. Court sites will be asked to provide a small space for the research team to enroll participants and provide the FTS intervention (if applicable). The sites will also be asked to refer potentially eligible individuals to the research team at times when they are on-site. ;

Related Conditions & MeSH terms

• Drug Overdose
• Harm Reduction
• Opiate Overdose

• NCT number: NCT05493475
• Study type: Interventional
• Source: Nationwide Children's Hospital
• Contact: Nichole Michaels, PhD
• Phone: 614-355-5870
• Email: nichole.michaels@nationwidechildrens.org
• Status: Recruiting
• Phase: N/A
• Start date: November 10, 2022
• Completion date: September 2025